# Varubi

NDC: 70720-101
Generic name: rolapitant
Labeler / Manufacturer: TerSera Therapeutics LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20151007

FDA application: NDA206500

## Active ingredients

- ROLAPITANT HYDROCHLORIDE: 90 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70720-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70720-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a52896cd-4a98-49b8-82db-bf1985a64d97